Federal Analog Act
E331256
The Federal Analog Act is a U.S. drug law that allows substances substantially similar to already controlled drugs to be treated as illegal controlled substances when intended for human consumption.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Federal Analog Act canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T3148706 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Federal Analog Act Context triple: [Controlled Substances Act, relatedTo, Federal Analog Act]
-
A.
FDC Act
The FDC Act is a key United States law that authorizes the Food and Drug Administration to regulate the safety, efficacy, and labeling of food, drugs, cosmetics, and certain medical devices.
-
B.
Federal Register Act
The Federal Register Act is a United States law that established the Federal Register system for officially publishing government rules, regulations, and notices.
-
C.
Federal Trade Commission Act provisions
The Federal Trade Commission Act provisions are U.S. federal laws that establish and empower the Federal Trade Commission to prevent unfair or deceptive business practices and promote consumer protection and fair competition.
-
D.
Federal Food, Drug, and Cosmetic Act
The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
-
E.
Controlled Substances Act
The Controlled Substances Act is a U.S. federal law that regulates the manufacture, distribution, and possession of certain drugs by classifying them into schedules based on their medical use and potential for abuse.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Federal Analog Act Target entity description: The Federal Analog Act is a U.S. drug law that allows substances substantially similar to already controlled drugs to be treated as illegal controlled substances when intended for human consumption.
-
A.
FDC Act
The FDC Act is a key United States law that authorizes the Food and Drug Administration to regulate the safety, efficacy, and labeling of food, drugs, cosmetics, and certain medical devices.
-
B.
Federal Register Act
The Federal Register Act is a United States law that established the Federal Register system for officially publishing government rules, regulations, and notices.
-
C.
Federal Trade Commission Act provisions
The Federal Trade Commission Act provisions are U.S. federal laws that establish and empower the Federal Trade Commission to prevent unfair or deceptive business practices and promote consumer protection and fair competition.
-
D.
Federal Food, Drug, and Cosmetic Act
The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
-
E.
Controlled Substances Act
The Controlled Substances Act is a U.S. federal law that regulates the manufacture, distribution, and possession of certain drugs by classifying them into schedules based on their medical use and potential for abuse.
- F. None of above. chosen
Statements (45)
| Predicate | Object |
|---|---|
| instanceOf |
United States federal drug law
ⓘ
statute ⓘ |
| aimsTo | close loopholes in federal drug control laws ⓘ |
| allows | prosecution of unscheduled substances as if scheduled ⓘ |
| appliesIn | federal courts, not state courts unless incorporated by state law ⓘ |
| appliesTo | controlled substance analogues ⓘ |
| associatedWith |
designer amphetamines
ⓘ
fentanyl analogues ⓘ synthetic cannabinoids ⓘ synthetic cathinones ⓘ |
| basisIn | Congressional concern over designer drugs in the 1980s ⓘ |
| classification | criminal law statute ⓘ |
| conditionForApplication |
substance must be intended for human consumption
ⓘ
substance must be substantially similar in chemical structure to a controlled substance in Schedule I or II ⓘ substance must be substantially similar in effect on the central nervous system to a controlled substance in Schedule I or II ⓘ |
| controversy |
challenges in proving chemical and pharmacological similarity
ⓘ
use of expert testimony to establish similarity ⓘ vagueness of the term substantially similar ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| doesNotAutomaticallyApplyTo | substances not intended for human consumption ⓘ |
| enforcedBy |
Drug Enforcement Administration
ⓘ
United States Department of Justice ⓘ |
| evidentiaryRequirement | government must prove similarity and intent beyond a reasonable doubt ⓘ |
| influences | law enforcement strategies against emerging synthetic drugs ⓘ |
| interpretationBy |
U.S. federal courts
ⓘ
surface form:
United States federal courts
|
| jurisdiction | federal jurisdiction of the United States ⓘ |
| legalEffect | treats certain analogues as Schedule I controlled substances ⓘ |
| legalStandard |
substantially similar chemical structure
ⓘ
substantially similar stimulant, depressant, or hallucinogenic effect ⓘ |
| partOf | Controlled Substances Act ⓘ |
| penaltyFramework | penalties comparable to those for Schedule I controlled substances ⓘ |
| purpose | to prevent circumvention of drug scheduling by minor chemical modifications ⓘ |
| relatedConcept |
controlled substance analogue
ⓘ
designer drug ⓘ novel psychoactive substance ⓘ |
| relatedTo | Controlled Substances Act scheduling system ⓘ |
| requires | comparison to a specific Schedule I or II substance ⓘ |
| requiresProofOf | intent for human consumption ⓘ |
| scope | applies to manufacture, distribution, and possession with intent to distribute analogues ⓘ |
| subjectMatter |
controlled substances regulation
ⓘ
drug analogues ⓘ |
| targets |
designer drugs
ⓘ
research chemicals sold for recreational use ⓘ |
| usedIn | federal criminal prosecutions involving synthetic drugs ⓘ |
| usedToProsecute | online sales of novel psychoactive substances ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Federal Analog Act Description of subject: The Federal Analog Act is a U.S. drug law that allows substances substantially similar to already controlled drugs to be treated as illegal controlled substances when intended for human consumption.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.